Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Revenue Recognition - Disaggregation of Revenue (Details)

v3.19.3.a.u2
Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue $ 106,868 $ 104,672 $ 101,713 $ 95,577 $ 76,475 $ 69,097 $ 67,746 $ 63,423 $ 408,830 $ 276,741 $ 240,251
Clinical Services                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue                 361,161 241,873 213,097
Pharma Services                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue                 47,669 34,868 27,154
Client direct billing | Clinical Services                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue                 212,703 164,888 147,726
Commercial Insurance | Clinical Services                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue                 83,107 40,360 35,473
Medicare and Medicaid | Clinical Services                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue                 64,745 35,566 29,493
Self-Pay | Clinical Services                      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                      
Total Revenue                 $ 606 $ 1,059 $ 405